Pfizer to seek approval for RSV vaccine for people as young as 18
An RSV vaccine already used for older adults could help protect people as young as 18 who are at increased risk of the disease, drugmaker Pfizer said.
Stay updated with breaking news from Tuesday Pfizer. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
An RSV vaccine already used for older adults could help protect people as young as 18 who are at increased risk of the disease, drugmaker Pfizer said.
Moderna asked the Food and Drug Administration for emergency authorization of a second booster of its COVID-19 vaccine for all adults.
On Tuesday Pfizer and BioNTech announced that they are planning to ask the Food and Drug Administration to authorize a second COVID-19 booster shot for people 6
WASHINGTON (Sputnik) - The pharmaceutical companies Pfizer and BioNTech said in a press release that they are seeking Emergency Use Authorization for their... 02.02.2022, Sputnik International
From Tuesday Pfizer booster shots are available for those who received their double dose of this vaccine more than six months ago.